PNKP
Bifunctional polynucleotide phosphatase/kinase
Also known as: PNK, PNKP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96T60
- Gene
- PNKP
- Ensembl
- ENSG00000039650
- Chromosome
- 19
- Canonical length
- 521 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
This locus represents a gene involved in DNA repair. In response to ionizing radiation or oxidative damage, the protein encoded by this locus catalyzes 5' phosphorylation and 3' dephosphorylation of nucleic acids. Mutations at this locus have been associated with microcephaly, seizures, and developmental delay.[provided by RefSeq, Sep 2010]
Canonical amino-acid sequenceUniProt
521 residues, UniProt reviewed canonical sequence.
>Q96T60|PNKP
1 MGEVEAPGRL WLESPPGGAP PIFLPSDGQA LVLGRGPLTQ VTDRKCSRTQ VELVADPETR
61 TVAVKQLGVN PSTTGTQELK PGLEGSLGVG DTLYLVNGLH PLTLRWEETR TPESQPDTPP
121 GTPLVSQDEK RDAELPKKRM RKSNPGWENL EKLLVFTAAG VKPQGKVAGF DLDGTLITTR
181 SGKVFPTGPS DWRILYPEIP RKLRELEAEG YKLVIFTNQM SIGRGKLPAE EFKAKVEAVV
241 EKLGVPFQVL VATHAGLYRK PVTGMWDHLQ EQANDGTPIS IGDSIFVGDA AGRPANWAPG
301 RKKKDFSCAD RLFALNLGLP FATPEEFFLK WPAAGFELPA FDPRTVSRSG PLCLPESRAL
361 LSASPEVVVA VGFPGAGKST FLKKHLVSAG YVHVNRDTLG SWQRCVTTCE TALKQGKRVA
421 IDNTNPDAAS RARYVQCARA AGVPCRCFLF TATLEQARHN NRFREMTDSS HIPVSDMVMY
481 GYRKQFEAPT LAEGFSAILE IPFRLWVEPR LGRLYCQFSE GLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PNKP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 46 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 46 nTPM
- spleen: 38 nTPM
- pituitary gland: 38 nTPM
- kidney: 33 nTPM
- thyroid gland: 32 nTPM
- pancreas: 29 nTPM
Single-cell type
- epididymal principal cells: 291 nCPM
- adrenal cortex cells: 139 nCPM
- breast lactating cells: 77 nCPM
- leydig cells: 76 nCPM
- syncytiotrophoblasts: 73 nCPM
- parietal cells: 73 nCPM
Immune cell
- neutrophil: 24 nTPM
- non-classical monocyte: 18 nTPM
- eosinophil: 17 nTPM
- classical monocyte: 12 nTPM
- naive B-cell: 12 nTPM
- intermediate monocyte: 12 nTPM
Brain region
- choroid plexus: 40 nTPM
- cerebral cortex: 22 nTPM
- hippocampal formation: 19 nTPM
- pons: 19 nTPM
- midbrain: 19 nTPM
- medulla oblongata: 18 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PNKP.
Disease | AllUniProt
Conditions PNKP is implicated in, by any mechanism.
- Microcephaly, seizures, and developmental delay (MCSZ) MIM:613402
- Ataxia-oculomotor apraxia 4 (AOA4) MIM:616267
Disease | GeneticClinVar
145 pathogenic / likely-pathogenic of 1,270 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Developmental and epileptic encephalopathy, 12
- Microcephaly, seizures, and developmental delay
- Ataxia - oculomotor apraxia type 4
- PNKP-related disorder
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.21
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.31
- DepMap mean gene effect
- -0.4
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- base-excision repair, gap-filling
- DNA repair
- DNA-templated DNA replication
- double-strand break repair via nonhomologous end joining
- nucleotide-excision repair
- positive regulation of double-strand break repair via nonhomologous end joining
- positive regulation of telomere maintenance
- response to oxidative stress
- response to radiation
Molecular functions
- ATP binding
- ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity
- damaged DNA binding
- double-stranded DNA binding
- endonuclease activity
- polynucleotide 3'-phosphatase activity
- purine nucleotide binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SMAD/FHA domain superfamily
- HAD superfamily
- P-loop containing nucleoside triphosphate hydrolase
- HAD-like superfamily
- PNK, FHA domain
- AAA domain
- FHA domain
- HAD-superfamily hydrolase,subfamily IIIA
- Bifunctional polynucleotide phosphatase/kinase PNKP
- Polynucleotide 3'-phosphatase
- Polynucleotide kinase 3 phosphatase
- Polynucleotide kinase 3 phosphatase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PNKP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PNKP as an antibody target. Whether an autoantibody or antibody against PNKP could matter depends on whether native PNKP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PNKP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PNKP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...